The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) is pleased to announce that Lundbeck and Innovative Pharma have joined the Federation, thus bringing its membership up to 28 leading international companies and 45 national and regional industry associations. Lundbeck is a global pharmaceutical company conducting research for the treatment of disorders in the central...
Read moreThe International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) is pleased to announce the addition of a new member, Otsuka Pharmaceutical Co., Ltd. (Otsuka), a subsidiary of Otsuka Holdings Co., Ltd., Japan’s second largest research-based pharmaceutical company group. Otsuka’s accession to IFPMA was approved at the Council meeting held on June 22, 2011. “Otsuka’s participation...
Read moreThe research-based pharmaceutical industry launches today a Framework for Action to respond to concerns that cardiovascular disease, cancer, diabetes and chronic respiratory diseases are posing mounting threats to public health as well as public and private finances worldwide. The industry’s ten-point Framework scopes out specific areas of action to tackle non-communicable diseases (NCDs) including innovation,...
Read moreAs one of the 189 nongovernmental organizations (NGOs) in official relations with the World Health Organization (WHO), and in line with WHO principles governing relations with NGOs, representatives of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) were present to listen to the proceedings of the 64 th World Health Assembly (WHA). The IFPMA...
Read moreIFPMA Statement, WHA 64, Item 13.12, Prevention and Control of Non Communicable Diseases Delivered by Mr Mario Ottiglio, Associate Director, Public Affairs and Global Health Policy Thank you on behalf of the International Federation of Pharmaceutical Manufacturers and Associations, the IFPMA, for the opportunity to provide our industry’s perspective on non-communicable diseases. The IFPMA represents...
Read moreIFPMA Statement under WHA 64 agenda item 13.7 Delivered by Mr Mario Ottiglio, Associate Director, Public Affairs & Global Health Policy On behalf of the International Federation of Pharmaceutical Manufacturers and Associations, the IFPMA, I thank you for the opportunity to address the issue related to fake medical products. Mr Chairman, Madame Director General, the...
Read moreThe research-based pharmaceutical industry, represented by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), welcomes the assessment of the global response to the 2009 H1N1 pandemic conducted by the independent International Health Regulations (IHR) Review Committee, whose final report was the subject of a resolution 1 approved by the World Health Assembly. The pandemic...
Read moreAs one of the 189 nongovernmental organizations (NGOs) in official relations with the World Health Organization (WHO), and in line with WHO principles governing relations with NGOs, representatives of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) will be present to listen to the proceedings of the 64th World Health Assembly (WHA). The IFPMA...
Read moreThe results of AIPM research show an insufficient level of diagnosis and low awareness of their personal health April 26, 2011, Moscow –Today The Association of International Pharmaceutical Manufacturers (AIPM) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) presented the survey entitled Population Attitude to Personal Health: Perception of Health, Understanding of Risk Factors, Morbidity and Mortality, conducted in Russia from January, 2011 to April, 2011. The findings show...
Read moreThe International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) welcomes the outcome of the WHO Open-Ended Working Group of Member States on Pandemic Influenza Preparedness (OEWG/PIP). The Working Group has reached a decision that will result in an effective global system to prepare for potential future influenza pandemics, recognizing a shared responsibility to help secure...
Read moreThe International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) today gives its support to the 2011 WHO World Health Day, which this year takes as its theme Anti-Microbial Resistance (AMR) and raises awareness of the problem of antibiotics losing their effectiveness over time as bacteria naturally evolve and mutate to become resistant to drug treatments....
Read more